JPWO2021132598A1 - - Google Patents

Info

Publication number
JPWO2021132598A1
JPWO2021132598A1 JP2021567692A JP2021567692A JPWO2021132598A1 JP WO2021132598 A1 JPWO2021132598 A1 JP WO2021132598A1 JP 2021567692 A JP2021567692 A JP 2021567692A JP 2021567692 A JP2021567692 A JP 2021567692A JP WO2021132598 A1 JPWO2021132598 A1 JP WO2021132598A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021567692A
Other languages
Japanese (ja)
Other versions
JP7617031B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021132598A1 publication Critical patent/JPWO2021132598A1/ja
Priority to JP2025000758A priority Critical patent/JP2025036714A/ja
Application granted granted Critical
Publication of JP7617031B2 publication Critical patent/JP7617031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2021567692A 2019-12-27 2020-12-25 水性組成物 Active JP7617031B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025000758A JP2025036714A (ja) 2019-12-27 2025-01-06 水性組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019239599 2019-12-27
JP2019239599 2019-12-27
PCT/JP2020/048835 WO2021132598A1 (ja) 2019-12-27 2020-12-25 水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025000758A Division JP2025036714A (ja) 2019-12-27 2025-01-06 水性組成物

Publications (2)

Publication Number Publication Date
JPWO2021132598A1 true JPWO2021132598A1 (https=) 2021-07-01
JP7617031B2 JP7617031B2 (ja) 2025-01-17

Family

ID=76574720

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021567692A Active JP7617031B2 (ja) 2019-12-27 2020-12-25 水性組成物
JP2025000758A Pending JP2025036714A (ja) 2019-12-27 2025-01-06 水性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025000758A Pending JP2025036714A (ja) 2019-12-27 2025-01-06 水性組成物

Country Status (6)

Country Link
US (1) US20230101139A1 (https=)
EP (2) EP4674401A3 (https=)
JP (2) JP7617031B2 (https=)
CN (2) CN119367282A (https=)
TW (2) TWI889740B (https=)
WO (1) WO2021132598A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
AU2021318236A1 (en) * 2020-07-30 2023-03-09 Rohto Pharmaceutical Co., Ltd. Aqueous composition
WO2024204749A1 (ja) * 2023-03-31 2024-10-03 ロート製薬株式会社 眼科組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046470A (ja) * 2007-07-11 2009-03-05 Pfizer Inc ドライアイ障害を治療する医薬組成物および方法
WO2011013785A1 (ja) * 2009-07-31 2011-02-03 日本たばこ産業株式会社 含窒素スピロ環化合物及びその医薬用途
JP2012062326A (ja) * 2004-12-28 2012-03-29 Rohto Pharmaceutical Co Ltd プラノプロフェン含有組成物
WO2015060208A1 (ja) * 2013-10-21 2015-04-30 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1251223A1 (en) 2015-07-07 2019-01-25 Japan Tobacco, Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
KR102728341B1 (ko) * 2015-09-24 2024-11-11 레오 파마 에이/에스 원형탈모증의 치료
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
JP7722931B2 (ja) * 2019-12-27 2025-08-13 ロート製薬株式会社 水性組成物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012062326A (ja) * 2004-12-28 2012-03-29 Rohto Pharmaceutical Co Ltd プラノプロフェン含有組成物
JP2009046470A (ja) * 2007-07-11 2009-03-05 Pfizer Inc ドライアイ障害を治療する医薬組成物および方法
WO2011013785A1 (ja) * 2009-07-31 2011-02-03 日本たばこ産業株式会社 含窒素スピロ環化合物及びその医薬用途
WO2015060208A1 (ja) * 2013-10-21 2015-04-30 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤

Also Published As

Publication number Publication date
TW202135821A (zh) 2021-10-01
US20230101139A1 (en) 2023-03-30
EP4070796B1 (en) 2025-12-24
EP4674401A2 (en) 2026-01-07
CN114867480A (zh) 2022-08-05
EP4674401A3 (en) 2026-02-25
TW202541813A (zh) 2025-11-01
EP4070796A1 (en) 2022-10-12
EP4070796A4 (en) 2024-01-17
TWI889740B (zh) 2025-07-11
JP2025036714A (ja) 2025-03-14
JP7617031B2 (ja) 2025-01-17
CN119367282A (zh) 2025-01-28
EP4070796C0 (en) 2025-12-24
WO2021132598A1 (ja) 2021-07-01

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021016821A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112019016138A2 (https=)
BR112019016142A2 (https=)
JPWO2021025129A1 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
JPWO2021132598A1 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021017310A2 (https=)
BR112021013128A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231214

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250106

R150 Certificate of patent or registration of utility model

Ref document number: 7617031

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150